Japan Home Healthcare Market Size, Share, and COVID-19 Impact Analysis, By Product (Therapeutic Products, Testing, Screening & Monitoring Products, and Mobility Care Products), By Service (Skilled Nursing, Rehabilitation Therapy, Hospice and Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy, and Pregnancy Care), By Indication (Cancer, Respiratory Diseases, Movement Disorders, Cardiovascular Diseases and Hypertension, Pregnancy, Wound Care, Diabetes, Hearing Disorders, and Others), and Japan Home Healthcare Market Insights, Industry Trend, Forecasts to 2035

Japan Home Healthcare Market Insights Forecasts to 2035

• The Japan Home Healthcare Market Size was Estimated at USD 22.8 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.91% from 2025 to 2035
• The Japan Home Healthcare Market Size is Expected to Reach USD 52.7 Billion by 2035

According to a research report published by Spherical Insights and Consulting, The Japan home healthcare market Size is anticipated to reach USD 52.7 Billion by 2035, growing at a CAGR of 7.91% from 2025 to 2035. The Japan home healthcare market is expanding due to its aging population, increase in chronic diseases, and growing demand for cost-efficient, in-home care. Government policies and technological developments further propel adoption, increasing access, efficiency, and quality of home healthcare services.

Market Overview

Japan's home healthcare market is defined as the medical care delivered at home by patients, involving chronic disease management, rehabilitation, and nursing care. It is a cost-effective option compared to hospitalization, especially for the elderly. The integration of digital health technologies, such as telemedicine, remote monitoring, and artificial intelligence-based tools, increases caregiving capabilities and efficiency. The innovations enable real-time health monitoring and personalized care plans, which improve patient outcomes. The market offers prospects for the development of assistive tools, the expansion of telemedicine services, and the development of AI-based health management platforms. These technologies seek to tackle the issue of caregiver shortages and the requirement for expandable healthcare solutions. The growing incidence of chronic diseases like diabetes and cardiovascular conditions further boosts the need for home-based care options. Policies have been put into place by the Japanese government to encourage home healthcare, such as updating telemedicine guidelines and creating reimbursement systems for home-based care treatments.

Report Coverage

This research report categorizes the market for the Japan home healthcare market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan home healthcare market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan home healthcare market.

Driving Factors

The Japan home healthcare market is motivated by its fast-growing elderly population, with more than 36 million people aged 65 and above, which pushes demand for in-home medical care. Increasing cases of chronic conditions like diabetes and cardiovascular diseases also contribute to the demand. Advances in technology, such as telemedicine and remote monitoring, optimize care provision. In addition, home-based care policies by the government and reimbursement systems promote uptake, such that home healthcare becomes a viable, affordable, and first-rate substitute for care provided in hospitals in Japan.

Restraining Factors

The home healthcare market in Japan is constrained by low numbers of trained caregivers, particularly in rural communities, where access remains poor. High operating expenses, regulatory barriers, and cultural preference for family care also hinder the uptake and increased roll-out of home healthcare services countrywide.

Market Segmentation

The Japan Home Healthcare Market share is classified into product, service, and indication.

• The therapeutic products segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan home healthcare market is segmented by product into therapeutic products, testing, screening & monitoring products, and mobility care products. Among these, the therapeutic products segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The therapeutic products are due to the rising incidence of long-term conditions such as diabetes and respiratory conditions. The aging population is driving demand for in-home treatment solutions such as oxygen therapy and dialysis. Such products facilitate long-term care at home and limit hospital visits and healthcare expenditures.

• The skilled nursing segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan home healthcare market is segmented by service into skilled nursing, rehabilitation therapy, hospice and palliative care, unskilled care, respiratory therapy, infusion therapy, and pregnancy care. Among these, the skilled nursing segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the fast-growing elderly population and prevalent rates of chronic disease in need of professional medical treatment. Medication management, wound care, and post-surgical care are critical services, lowering hospital readmissions and helping geriatric patients receive safe, ongoing care at home.

• The cancer segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan home healthcare market is segmented by indication into cancer, respiratory diseases, movement disorders, cardiovascular diseases and hypertension, pregnancy, wound Care, diabetes, hearing disorders, and others. Among these, the cancer segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to the high incidence of cancer, particularly among older adults. Cancer care in the home reinforces palliative therapy, relief from pain, and psychosocial support, minimizing hospitalization dependency while improving quality and comfort for patients in a comfortable, personalized home setting.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan home healthcare market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Medtronic Japan Co., Ltd.
• GE Healthcare Japan Corporation
• Nihon Kohden
• JMS Co., Ltd.
• Daiichi Sankyo
• Omron Healthcare
• Abbott Japan Co., Ltd.
• Mitsubishi Tanabe
• 3M Japan Limited
• Nichii Gakkan Group
• Takeda Corporation
• Others

Recent Developments:

• In November 2023, Nippon Life Insurance revealed strategic plans to acquire Nichii Holdings, the group company of Nichii Gakkan, a Japan-resident in-home nursing care service provider, at around USD 1.41 billion.

• In September 2023, Sompo, a top commercial insurance service provider in Japan, collaborated with TytoCare, an Israeli telemedicine startup, to deploy the startup's artificial intelligence-enabled remote medical device for older nursing care services.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan home healthcare market based on the below-mentioned segments:

Japan Home Healthcare Market, By Product

• Therapeutic Products
• Testing, Screening & Monitoring Products
• Mobility Care Products

Japan Home Healthcare Market, By Service

• Skilled Nursing
• Rehabilitation Therapy
• Hospice and Palliative Care
• Unskilled Care
• Respiratory Therapy
• Infusion Therapy
• Pregnancy Care

Japan Home Healthcare Market, By Indication

• Cancer
• Respiratory Diseases
• Movement Disorders
• Cardiovascular Diseases and Hypertension
• Pregnancy
• Wound Care
• Diabetes
• Hearing Disorders
• Others